These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Comparative study on the use of anticoagulants heparin and recombinant hirudin in a rabbit traumatic anastomosis model. Fu K; Izquierdo R; Walenga JM; Fareed J Thromb Res; 1995 Jun; 78(5):421-8. PubMed ID: 7660358 [TBL] [Abstract][Full Text] [Related]
5. A blinded trial of local recombinant tissue factor pathway inhibitor versus either local or systemic heparin in a vein bypass model. Rapp JH; Pan XM; Ghermay A; Gazetas P; Brady SE; Reilly LM J Vasc Surg; 1997 Apr; 25(4):726-9. PubMed ID: 9129630 [TBL] [Abstract][Full Text] [Related]
8. Effects of enoxaparin, standard heparin, and streptokinase on the patency of anastomoses in severely crushed arteries. Chen LE; Seaber AV; Korompilias AV; Urbaniak JR Microsurgery; 1995; 16(10):661-5. PubMed ID: 8676728 [TBL] [Abstract][Full Text] [Related]
13. Combination of a brief irrigation with tissue factor pathway inhibitor (TFPI) and adenovirus-mediated local TFPI gene transfer additively reduces neointima formation in balloon-injured rabbit carotid arteries. Atsuchi N; Nishida T; Marutsuka K; Asada Y; Kamikubo Y; Takeshita A; Ueno H Circulation; 2001 Jan; 103(4):570-5. PubMed ID: 11157724 [TBL] [Abstract][Full Text] [Related]
14. Topical heparin enhances patency in a rat model of arterial thrombosis. Braam MJ; Cooley BC; Gould JS Ann Plast Surg; 1995 Feb; 34(2):148-51; discussion 151-3. PubMed ID: 7741432 [TBL] [Abstract][Full Text] [Related]
15. Prevention of experimental arterial thrombosis by topical administration of active site-inactivated factor VIIa. Arnljots B; Ezban M; Hedner U J Vasc Surg; 1997 Feb; 25(2):341-6. PubMed ID: 9052569 [TBL] [Abstract][Full Text] [Related]
16. Topically applied tissue factor pathway inhibitor reduced intimal thickness of small arterial autografts in rabbits. Sun LB; Utoh J; Moriyama S; Tagami H; Okamoto K; Kitamura N J Vasc Surg; 2001 Jul; 34(1):151-5. PubMed ID: 11436089 [TBL] [Abstract][Full Text] [Related]
17. Topical application of low molecular weight heparin in a rabbit traumatic anastomosis model. Fu K; Izquierdo R; Vandevender D; Warpeha RL; Wolf H; Fareed J Thromb Res; 1997 Jun; 86(5):355-61. PubMed ID: 9211626 [TBL] [Abstract][Full Text] [Related]
18. Does glycosylation influence the experimental antithrombotic effect of a two-domain tissue factor pathway inhibitor? Holst J; Lindblad B; Nordfang O; Ostergaard PB; Hedner U Haemostasis; 1996; 26(1):23-30. PubMed ID: 8698275 [TBL] [Abstract][Full Text] [Related]
19. Active site-inactivated factor VIIa prevents thrombosis without increased surgical bleeding: topical and intravenous administration in a rat model of deep arterial injury. Söderström T; Hedner U; Arnljots B J Vasc Surg; 2001 May; 33(5):1072-9. PubMed ID: 11331851 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of microarterial thrombosis by activated protein C in a rabbit model. Arnljots B; Bergqvist D; Dahlbäck B Thromb Haemost; 1994 Sep; 72(3):415-20. PubMed ID: 7855793 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]